CPT Code 38241: Hematopoietic Progenitor Cell (HPC); Autologous Transplantation

Know more about the 38241 CPT code, its modifiers, and reimbursement insights to navigate billing effectively.

What is CPT code 38241?

CPT code 38241 is used for the autologous transplantation of hematopoietic progenitor cell (HPC) procedures, serving as a critical component in the treatment of various hematologic malignancies and blood disorders. This code specifically applies when a patient receives their own previously collected stem cells back through transplantation, distinguishing it from allogeneic procedures where cells come from a donor.

The procedure involves the infusion of previously harvested and processed hematopoietic progenitor cells back into the same patient following high-dose chemotherapy or radiation therapy. This transplantation approach allows physicians to deliver intensive treatment regimens that would otherwise be lethal to the bone marrow, with the patient's own stem cells providing the necessary support for hematopoietic recovery.

Medical necessity for CPT code 38241 typically involves conditions where high-dose therapy offers the best chance for cure or prolonged remission. Common indications include multiple myeloma, lymphomas, and certain solid tumors where autologous transplantation has demonstrated clinical benefit. The procedure requires extensive evaluation and preparation, with physicians conducting comprehensive assessments to determine patient eligibility and optimal timing.

The transplantation process involves multiple phases, from initial stem cell collection through conditioning regimens and finally the reinfusion procedure that CPT code 38241 specifically describes. This code captures the technical and professional components of the actual cell infusion, which typically takes place in a specialized hospital setting with appropriate monitoring and support services.

CPT code 38241 documentation requirements

Comprehensive documentation for CPT code 38241 must demonstrate medical necessity and support the complex nature of autologous transplantation procedures. The essential documentation includes:

The documentation must include detailed information about the conditioning regimen used prior to transplantation, including specific chemotherapy agents, radiation therapy if applicable, and the patient's response to treatment.
Physicians must document the source and characteristics of the hematopoietic progenitor cells being transplanted, including collection dates, processing procedures, and cell viability assessments.
The record must show that the patient met established criteria for autologous transplantation and that alternative treatments were considered or previously attempted.
The actual transplantation procedure documentation must describe the infusion process, including the volume of cells administered, infusion rate, and any complications encountered during the procedure.
Documentation must also clearly indicate the date and time of the procedure, the hospital location where it was performed, and the physicians involved in the transplantation process.
The medical record must include quality assurance documentation related to the hematopoietic progenitor cell product, including processing reports, contamination testing results, and viability assessments.
Documentation should address any special processing requirements for the cell product, including cryopreservation protocols, thawing procedures, and washing techniques used to prepare the cells for infusion.

All this detailed information may be required for review by Medicare Administrative Contractors (MAC) or other payers during claims processing.

CPT code 38241 billing guidelines

Billing for CPT code 38241 requires adherence to specific guidelines established by Medicare and other payers, with particular attention to medical necessity requirements and documentation standards.

Coverage limitations and restrictions

Medicare coverage for autologous transplantation is subject to specific limitations based on the patient's diagnosis and clinical circumstances. The procedure must be performed for approved indications as outlined in national coverage determinations, and any deviation from these criteria may result in coverage denials. Physicians must ensure that the patient's condition meets the established medical necessity criteria before proceeding with the procedure.

The billing process requires careful attention to timing restrictions, as repeated procedures may be subject to additional review and approval requirements.

Hospital and facility billing considerations

The hospital bills for the facility components of the procedure, including the cell processing, storage, and infusion supplies, while physicians bill for the professional services related to the transplantation procedure.

Special considerations and billing limitations

The billing for autologous transplantation procedures is subject to various limitations and restrictions that may change over time based on updated coverage policies and clinical evidence. Physicians must stay current with these requirements and ensure that their billing practices align with current Medicare policies and procedures.

Same day procedures may involve additional considerations for billing and documentation, particularly when multiple related services are provided during the transplantation process.

Coverage determinations are subject to periodic review and may be updated based on new clinical evidence or changes in medical practice. These modifications can affect billing requirements and may require adjustments to documentation practices or procedure protocols.

Other relevant codes

The following codes are commonly used in conjunction with or as alternatives to CPT code 38241:

CPT code 38240: Hematopoietic progenitor cell (HPC); allogeneic transplantation per donor
CPT code 38242: Allogeneic lymphocyte infusions for donor lymphocyte infusion procedures performed after transplantation
CPT code 38243: HPC; HPC boost for additional stem cell infusions following initial transplantation

Frequently asked questions

CPT code 38241 is specifically used to bill for autologous hematopoietic progenitor cell transplantation, which involves the reinfusion of a patient’s own stem cells collected previously for transplantation purposes. It is appropriate and intended for autologous transplants only, not for allogeneic or other types of transplants.

You can bill 38241 more than once only if multiple distinct autologous transplant procedures occur on separate occasions, but not multiple times for the same transplant session; repeat procedures require appropriate modifiers and documentation to support medical necessity and distinct services.

Services not included in 38241 typically encompass the harvesting or collection of the stem cells (reported separately with codes like 38206 or 38232), preparatory procedures such as cryopreservation or thawing, and post-transplant care or monitoring; these must be billed with their respective codes and are not bundled into 38241.